SCHEMBL3682259

SCHEMBL3682259

O=C(O)C(C(=O)O)c1cccc(C(F)(F)F)c1C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACP3 P15309 1/20 0.41
CNR2 P34972 2/20 0.41
PPARG P37231 2/20 0.38
P2RX7 Q99572 1/20 0.38
SRC P12931 1/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
IDO1 P14902 1/20 0.36
TDO2 P48775 1/20 0.36
POLQ O75417 1/20 0.36
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
NFKB1 P19838 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
TAS2R14 Q9NYV8 2/20 0.35
CACNA2D1 P54289 1/20 0.35
CACNA1B Q00975 1/20 0.35
CACNB1 Q02641 1/20 0.35
CACNA1C Q13936 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6676317 0.84 ACP3 (0.41) ACP3CNR2PPARGP2RX7LMNA
SCHEMBL6680423 0.84 ACP3 (0.41) ACP3CNR2PPARGP2RX7LMNA
SCHEMBL6676308 0.84 ACP3 (0.41) ACP3CNR2PPARGP2RX7LMNA
SCHEMBL28821897 0.83 ACP3 (0.53) ACP3CNR2PPARGSRCLMNA
SCHEMBL5452247 0.82 IDO1 (0.49) ACP3CNR2PPARGP2RX7SRC
SCHEMBL8587546 0.80 CTSS (0.38) ACP3CNR2PPARGP2RX7IDO1
SCHEMBL20954016 0.75 CA2 (0.41) SRCALDH1A1
SCHEMBL4982673 0.74 P2RX7 (0.47) ACP3CNR2P2RX7LMNAIDO1
SCHEMBL7682991 0.74 ACP3 (0.47) ACP3CNR2PPARGSRCLMNA
SCHEMBL13453951 0.73 P2RX7 (0.50) ACP3P2RX7LMNAIDO1TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056820-A1 Method for the production of substituted 2-aryl malonic acid esters BASF SE (DE) 2010-03-04 US disclosed
EP-1077208-A3 Process for the preparation of (bis-(trifluormethyl)-phenyl)-acetic acids and their alkyl esters as well as dialkyl esters of (bis-(trifluormethyl)-phenyl)-malonic acid BAYER AG (DE) 2003-01-02 EP disclosed
US-6395921-B1 DEPROTINATION, COPPER SALT AND DILUENTS, HYDROLYSIS AND DECARBOXYLATION BAYER AKTIENGESELLSCHAFT (DE) 2002-05-28 US disclosed
US-6395921-B1 DEPROTINATION, COPPER SALT AND DILUENTS, HYDROLYSIS AND DECARBOXYLATION BAYER AKTIENGESELLSCHAFT (DE) 2002-05-28 US disclosed
US-6395921-B1 DEPROTINATION, COPPER SALT AND DILUENTS, HYDROLYSIS AND DECARBOXYLATION BAYER AKTIENGESELLSCHAFT (DE) 2002-05-28 US disclosed
JP-2001081065-A METHOD FOR PRODUCING [BIS-(TRIFLUOROMETHYL)-PHENYL]- ACETIC ACID, ITS ALKYL ESTER AND DIALKYL BIS-(TRIFLUOROMETHYL)-PHENYL]-MALONATE BAYER AG 2001-03-27 JP disclosed
EP-1077208-A2 Process for the preparation of (bis-(trifluormethyl)-phenyl)-acetic acids and their alkyl esters as well as dialkyl esters of (bis-(trifluormethyl)-phenyl)-malonic acid BAYER AG (DE) 2001-02-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056820-A1 Method for the production of substituted 2-aryl malonic acid esters ME1, AKR1C3, AKR1C4 ACP3 2398/4885CNR2 857/4885PPARG 1353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.